5-bromo-2-[1-[1-(5-cyclopropylpyrimidin-2-yl)piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine
C20H22BrN5OS — CID 131985240
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-2-[1-[1-(5-cyclopropylpyrimidin-2-yl)piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine
5-bromo-2-[1-[1-(5-cyclopropylpyrimidin-2-yl)piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine (PubChem CID 131985240) has the molecular formula C20H22BrN5OS and a molecular weight of 460.40 g/mol. Its IUPAC name is 5-bromo-2-[1-[1-(5-cyclopropylpyrimidin-2-yl)piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine.
Molecular Properties
| Compound Name | 5-bromo-2-[1-[1-(5-cyclopropylpyrimidin-2-yl)piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine |
|---|---|
| PubChem CID | 131985240 |
| Molecular Formula | C20H22BrN5OS |
| Molecular Weight | 460.40 g/mol |
| Exact Mass | 459.07 |
| IUPAC Name | 5-bromo-2-[1-[1-(5-cyclopropylpyrimidin-2-yl)piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine |
| SMILES | CC(Oc1nc2ccc(Br)nc2s1)C1CCN(c2ncc(C3CC3)cn2)CC1 |
| InChI | InChI=1S/C20H22BrN5OS/c1-12(27-20-24-16-4-5-17(21)25-18(16)28-20)13-6-8-26(9-7-13)19-22-10-15(11-23-19)14-2-3-14/h4-5,10-14H,2-3,6-9H2,1H3 |
| InChIKey | JUSKSRNNMWKAKD-UHFFFAOYSA-N |
| XLogP | 4.81 |
| TPSA | 64.03 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 460.40 |
| LogP ≤ 5 | 4.81 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131985240 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.